Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Glioblastoma 9Neoplasms 3Medulloblastoma 2Brain Neoplasms 2Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1Glioma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Fulvestrant 62Paclitaxel 52Letrozole 51pembrolizumab 39Trastuzumab 38ribociclib 37Capecitabine 36Specimen Handling 34palbociclib 33Carboplatin 33Anastrozole 33exemestane 30Tamoxifen 30abemaciclib 29Cyclophosphamide 26pertuzumab 25Magnetic Resonance Spectroscopy 25trastuzumab deruxtecan 24Surveys and Questionnaires 20Blood Specimen Collection 20Radiotherapy 19olaparib 17Biopsy 16130-nm albumin-bound paclitaxel 16Standard of Care 15Docetaxel 15eribulin 14Methods 14Early Intervention, Educational 14inavolisib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Lomustine × 90 days × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡